Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Alzheimer's Disease

  Free Subscription


Articles published in Am J Geriatr Psychiatry

Retrieve available abstracts of 50 articles:
HTML format



Single Articles


    December 2025
  1. CHERUBINI V, Prata O, Fattobene L, Ceravolo MG, et al
    Profiles of Vulnerability to Financial Exploitation in the Degenerative Dementias.
    Am J Geriatr Psychiatry. 2025;33:1290-1300.
    PubMed     Abstract available


    November 2025
  2. NGUYEN HT, Nguyen BT, Nguyen PQ, Nguyen BH, et al
    A Screening Protocol to Identify Older Adults With Dementia and Their Family Caregivers in Northern Vietnam.
    Am J Geriatr Psychiatry. 2025;33:1134-1144.
    PubMed     Abstract available


    July 2025
  3. TALMASOV D, Johnson AS, Brown PJ, Provenzano FA, et al
    Depressive Symptoms Correlate With Tau Accumulation Rates in Amyloid Positive Adults.
    Am J Geriatr Psychiatry. 2025;33:756-769.
    PubMed     Abstract available


    June 2025
  4. GILDENGERS A, Weinstein AM, Gujral S, Zeng X, et al
    Corrigendum to "Where do plasma biomarkers fit in with current Alzheimer's disease detection?" [volume 33, issue 4, April 2025, pages 428-437].
    Am J Geriatr Psychiatry. 2025 Jun 27:S1064-7481(25)00395.
    PubMed    


  5. AMANO T, Inoue M, Dixit S, Tarafder A, et al
    Ethnoracial Disparities in Advance Care Planning Among People With Alzheimer's Disease and Related Dementias.
    Am J Geriatr Psychiatry. 2025 Jun 12:S1064-7481(25)00364.
    PubMed     Abstract available


  6. BONAR EE, Tan CY, Patyk A, Lei L, et al
    Agitation in Alzheimer's Disease as a Qualifying Condition for Medical Cannabis in the United States: A Brief Report on Current Trends.
    Am J Geriatr Psychiatry. 2025 Jun 11:S1064-7481(25)00363.
    PubMed     Abstract available


    May 2025
  7. GONZALEZ DA, Finley JA, Patel SES, Soble JR, et al
    Practical Assessment of Neuropsychiatric Symptoms: Updated Reliability, Validity, and Cutoffs for the Neuropsychiatric Inventory Questionnaire.
    Am J Geriatr Psychiatry. 2025;33:524-534.
    PubMed     Abstract available


    April 2025
  8. YANG Y, Kwak YT
    Network Analysis of Delusion Subtypes in Amyloid PET-Positive, Drug-Naive Alzheimer's Disease Patients.
    Am J Geriatr Psychiatry. 2025 Apr 22:S1064-7481(25)00329.
    PubMed     Abstract available


    March 2025
  9. KARGAR A, Fetratjoo DH, Moattar R, Tarki A, et al
    Efficacy of Add-On Agomelatine on Agitation, Aggression, and Neuroprotection in Alzheimer's Disease: A Randomized, Blinded, Controlled Trial.
    Am J Geriatr Psychiatry. 2025 Mar 20:S1064-7481(25)00082.
    PubMed     Abstract available


  10. TAN WY, Hargreaves CA, Dawe GS, Hsu W, et al
    Incremental Value of Multidomain Risk Factors for Dementia Prediction: A Machine Learning Approach.
    Am J Geriatr Psychiatry. 2025;33:229-244.
    PubMed     Abstract available


    February 2025
  11. PLYS E, Moss KO, Jacklin K, Yazzie M, et al
    Discontinuing the Term "Stakeholder" From the NIA IMPACT Collaboratory Engaging Partners Team: An Example of the Process of Language Change in an Organization.
    Am J Geriatr Psychiatry. 2025;33:192-199.
    PubMed     Abstract available


  12. CHU CS, Cheng SL, Bai YM, Su TP, et al
    Risk of Dementia in Different Types of Cancer Survivors: A Nationwide Cohort Study.
    Am J Geriatr Psychiatry. 2025;33:156-166.
    PubMed     Abstract available


    January 2025
  13. LEE H, Kim BH, Lee EH, Shin D, et al
    Corrigendum to "Brain Metabolic Resiliencein Alzheimer's Disease: A Predictor of Cognitive Decline and Conversion to Dementia [Am J of Geriatric Psychiatry (2024) in press, 1-11].
    Am J Geriatr Psychiatry. 2025 Jan 21:S1064-7481(25)00016.
    PubMed    


    December 2024
  14. LEE H, Kim BH, Lee EH, Shin D, et al
    Brain Metabolic Resilience in Alzheimer's Disease: A Predictor of Cognitive Decline and Conversion to Dementia.
    Am J Geriatr Psychiatry. 2024 Dec 3:S1064-7481(24)00543.
    PubMed     Abstract available


  15. CHEN J, Jang S, Wang MQ
    Medicare Payments and ACOs for Dementia Patients Across Race and Social Vulnerability.
    Am J Geriatr Psychiatry. 2024;32:1433-1442.
    PubMed     Abstract available


    November 2024
  16. MOREHOUSE CR, Hendriks S, Rabbee N, Kim SY, et al
    Do Caregivers Value the New Antiamyloid Treatments for Alzheimer's Disease More Than Home-Based Care?
    Am J Geriatr Psychiatry. 2024 Nov 26:S1064-7481(24)00541.
    PubMed     Abstract available


  17. AGA VM
    Brexpiprazole for the Treatment of Agitation in Alzheimer's Disease Dementia: Clinical Uncertainties and the Path Forward.
    Am J Geriatr Psychiatry. 2024 Nov 19:S1064-7481(24)00533.
    PubMed     Abstract available


    October 2024
  18. ALSHIBAN A, Hasoglu T, Oster J
    Efficacy And Safety of Dual Orexin Receptor Antagonist (DORA) For Sleep Disturbance in Patients With Alzheimer's Disease Dementia. A Review Article.
    Am J Geriatr Psychiatry. 2024 Oct 3:S1064-7481(24)00480.
    PubMed     Abstract available


  19. LEE S, Zide BS, Palm ST, Drew WJ, et al
    Specific Association of Worry With Amyloid-beta But Not Tau in Cognitively Unimpaired Older Adults.
    Am J Geriatr Psychiatry. 2024;32:1203-1214.
    PubMed     Abstract available


  20. GILDENGERS A, Weinstein AM, Gujral S, Zeng X, et al
    Where Do Plasma Biomarkers fit in With Current Alzheimer's Disease Detection?
    Am J Geriatr Psychiatry. 2024 Oct 1:S1064-7481(24)00478.
    PubMed     Abstract available


    August 2024
  21. KHASNAVIS S, O'Dell RS, van Dyck CH, Mecca AP, et al
    Commentary on "Study Partner Report of Apathy in Older Adults is Associated With AD Biomarkers: Findings From the Harvard Aging Brain Study".
    Am J Geriatr Psychiatry. 2024;32:920-921.
    PubMed    


  22. BURLING JE, Katz Z, Yuan Z, Munro C, et al
    Study Partner Report of Apathy in Older Adults is Associated with AD Biomarkers: Findings from the Harvard Aging Brain Study.
    Am J Geriatr Psychiatry. 2024;32:909-919.
    PubMed     Abstract available


    July 2024
  23. VANDE CASTEELE T, Laroy M, Van Cauwenberge M, Vanderlinden G, et al
    Late Life Depression is Not Associated With Alzheimer-Type Tau: Preliminary Evidence From a Next-Generation Tau Ligand PET-MR Study.
    Am J Geriatr Psychiatry. 2024 Jul 18:S1064-7481(24)00401.
    PubMed     Abstract available


  24. LANCTOT KL
    Commentary on Neuropsychiatric Symptom Profile in Alzheimer's Disease and their Relationship with Functional Decline.
    Am J Geriatr Psychiatry. 2024 Jul 16:S1064-7481(24)00400.
    PubMed    


  25. VAN DEN BULCKE L, Davidoff H, Heremans E, Potts Y, et al
    Acoustic Stimulation to Improve Slow-Wave Sleep in Alzheimer's Disease: A Multiple Night At-Home Intervention.
    Am J Geriatr Psychiatry. 2024 Jul 8:S1064-7481(24)00384.
    PubMed     Abstract available


  26. ZANDBAGLEH A, Miltiadous A, Sanei S, Azami H, et al
    Beta-to-Theta Entropy Ratio of EEG in Aging, Frontotemporal Dementia, and Alzheimer's Dementia.
    Am J Geriatr Psychiatry. 2024 Jul 4:S1064-7481(24)00380.
    PubMed     Abstract available


    June 2024
  27. ZHU CW, Schneider LS, Elder GA, Soleimani L, et al
    Neuropsychiatric Symptom Profile in Alzheimer's Disease and Their Relationship With Functional Decline.
    Am J Geriatr Psychiatry. 2024 Jun 29:S1064-7481(24)00375.
    PubMed     Abstract available


  28. SHAW JS, Leoutsakos JM, Rosenberg PB
    The Relationship Between First Presenting Neuropsychiatric Symptoms in Older Adults and Autopsy-Confirmed Memory Disorders.
    Am J Geriatr Psychiatry. 2024;32:754-764.
    PubMed     Abstract available


  29. GALLET Q, Bouteloup V, Locatelli M, Habert MO, et al
    Cerebral Metabolic Signature of Chronic Benzodiazepine Use in Nondemented Older Adults: An FDG-PET Study in the MEMENTO Cohort.
    Am J Geriatr Psychiatry. 2024;32:665-677.
    PubMed     Abstract available


    March 2024
  30. JANG S, Chen J
    National Estimates of Incremental Work Absenteeism Costs Associated With Adult Children of Parents With Alzheimer's Disease and Related Dementias.
    Am J Geriatr Psychiatry. 2024 Mar 28:S1064-7481(24)00294.
    PubMed     Abstract available


  31. TWAIT EL, Kamarioti M, Verberk IMW, Teunissen CE, et al
    Depressive Symptoms and Plasma Markers of Alzheimer's Disease and Neurodegeneration: A Coordinated Meta-Analysis of 8 Cohort Studies.
    Am J Geriatr Psychiatry. 2024 Mar 11:S1064-7481(24)00274.
    PubMed     Abstract available


  32. SISTI A, Gutman R, Mor V, Dionne L, et al
    Using Structured Observations to Evaluate the Effects of a Personalized Music Intervention on Agitated Behaviors and Mood in Nursing Home Residents With Dementia: Results From an Embedded, Pragmatic Randomized Controlled Trial.
    Am J Geriatr Psychiatry. 2024;32:300-311.
    PubMed     Abstract available


    January 2024
  33. DINIZ BS
    Immunotherapy in Alzheimer's Disease: From the Bench to the Bedside.
    Am J Geriatr Psychiatry. 2024 Jan 14:S1064-7481(24)00013.
    PubMed    


    December 2023
  34. ZHAI Z, Kong F, Zhu Z, Dai J, et al
    Effect and Potential Mechanism of Immunotherapy on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Am J Geriatr Psychiatry. 2023 Dec 7:S1064-7481(23)00491.
    PubMed     Abstract available


  35. KERCKHOVE N, Bornier N, Mulliez A, Elyn A, et al
    Prevalence of Chronic Pain Among People with Dementia: A Nationwide Study Using French Administrative Data.
    Am J Geriatr Psychiatry. 2023;31:1149-1163.
    PubMed     Abstract available


  36. LANCTOT KL, Rivet L, Tumati S, Perin J, et al
    Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial.
    Am J Geriatr Psychiatry. 2023;31:1077-1087.
    PubMed     Abstract available


    October 2023
  37. FENG V, Lanctot K, Herrmann N, Kiss A, et al
    Lipopolysaccharide, Immune Biomarkers and Cerebral Amyloid-Beta Deposition in Older Adults With Mild Cognitive Impairment & Major Depressive Disorder.
    Am J Geriatr Psychiatry. 2023;31:786-795.
    PubMed     Abstract available


    September 2023
  38. FU JF
    Assessment of Gray Matter Microstructure and Synaptic Density in Alzheimer's Disease: A Multimodal Imaging Study With DTI and SV2A PET: A Commentary on Silva-Rudberg et al.
    Am J Geriatr Psychiatry. 2023 Sep 14:S1064-7481(23)00408.
    PubMed    


    August 2023
  39. JOE E, Segal-Gidan F, Cummings JL, Galasko D, et al
    Association Between Self- and Proxy-Reported Depression and Quality of Life in Mild-Moderate Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2023 Aug 24:S1064-7481(23)00389.
    PubMed     Abstract available


  40. GRILL JD
    Remaining Questions in a Brave New World of Alzheimer's Disease Care.
    Am J Geriatr Psychiatry. 2023 Aug 19:S1064-7481(23)00391.
    PubMed    


  41. KIM JE, Tamres LK, Orbell SL, Cheng RZ, et al
    "And Does That Necessarily Mean Absolutely Alzheimer's?" An Analysis of Questions Raised Following Amyloid PET Results Disclosure.
    Am J Geriatr Psychiatry. 2023 Aug 13:S1064-7481(23)00388.
    PubMed     Abstract available


  42. SILVA-RUDBERG JA, Salardini E, O'Dell RS, Chen MK, et al
    Assessment of Gray Matter Microstructure and Synaptic Density in Alzheimer's Disease: A Multimodal Imaging Study With DTI and SV2A PET.
    Am J Geriatr Psychiatry. 2023 Aug 11:S1064-7481(23)00386.
    PubMed     Abstract available


  43. HINKLE JT, Pontone GM
    Invited Perspective on "BPSD Patterns in Patients With Severe Neuropsychiatric Disturbances: Insight From the RECAGE Study" (Cognat et al. 2023): Roles for nosology and neurobiology in understanding the heterogeneity of BPSD.
    Am J Geriatr Psychiatry. 2023;31:640-642.
    PubMed    


  44. COGNAT E, Sabia S, Fayel A, Lilamand M, et al
    BPSD Patterns in Patients With Severe Neuropsychiatric Disturbances: Insight From the RECAGE Study.
    Am J Geriatr Psychiatry. 2023;31:633-639.
    PubMed     Abstract available


  45. GINTERS M, Talaslahti T, Palm A, Kautiainen H, et al
    Criminal Behaviour After Diagnosis of a Neurocognitive Disorder: A Nationwide Finnish Register Study.
    Am J Geriatr Psychiatry. 2023;31:598-606.
    PubMed     Abstract available


    July 2023
  46. BABULAL GM, Chen L, Murphy SA, Doherty JM, et al
    Neuropsychiatric Symptoms and Alzheimer Disease Biomarkers Independently Predict Progression to Incident Cognitive Impairment.
    Am J Geriatr Psychiatry. 2023 Jul 26:S1064-7481(23)00368.
    PubMed     Abstract available


  47. LAMAR M, Arfanakis K, Yu L, Kapasi A, et al
    The Relationship of MRI-Derived Alzheimer's and Cerebrovascular-Related Signatures With Level of and Change in Health and Financial Literacy.
    Am J Geriatr Psychiatry. 2023 Jul 22:S1064-7481(23)00367.
    PubMed     Abstract available


  48. ASHFORD JW
    Neuroplasticity: The Critical Issue for Alzheimer's Disease and Links to Obesity and Depression.
    Am J Geriatr Psychiatry. 2023 Jul 15:S1064-7481(23)00354.
    PubMed    


    June 2023
  49. LY M, Yu GZ, Mian A, Cramer A, et al
    Neuroinflammation: A Modifiable Pathway Linking Obesity, Alzheimer's disease, and Depression.
    Am J Geriatr Psychiatry. 2023 Jun 11:S1064-7481(23)00318.
    PubMed     Abstract available


    February 2023
  50. KUNICKI ZJ, Frietchen R, McGeary JE, Jiang L, et al
    Prevalence of Comorbid Depression and Insomnia Among Veterans Hospitalized for Heart Failure with Alzheimer Disease and Related Disorders.
    Am J Geriatr Psychiatry. 2023 Feb 8:S1064-7481(23)00163.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.